Related Experiment Video
Updated: Aug 5, 2026

04:00
Corneal Sensitivity Testing Procedure for Ophthalmologic and Optometric Patients
Published on: August 2, 2024
Making Corneal Sensation Testing Accessible: Bench Validation of a Low-Cost Adjustable Monofilament Aesthesiometer
1Harrogate District Hospital, Harrogate, UK. d.maskill@nhs.net.
Summary
A low-cost, adjustable monofilament corneal aesthesiometer (GAMCA) effectively replicates the performance of the expensive Cochet-Bonnet (COBO) device. This affordable tool offers a viable alternative for accurate corneal sensation testing in various clinical settings.
Area of Science:
- Ophthalmology
- Biomedical Engineering
- Medical Devices
Background:
- Corneal sensation testing is crucial for diagnosing and monitoring neurotrophic keratopathy.
- The gold-standard Cochet-Bonnet (COBO) aesthesiometer is expensive and not widely available.
- Current alternatives like cotton wisps are qualitative and lack sensitivity.
Purpose of the Study:
- To evaluate a generic adjustable monofilament corneal aesthesiometer (GAMCA) for its ability to replicate COBO performance.
- To assess the feasibility of fabricating a low-cost corneal aesthesiometer using commodity materials.
Main Methods:
- A GAMCA was constructed for approximately £10.28, featuring an adjustable nylon monofilament.
- Two devices were validated against published COBO reference pressures using precision balance and corneal phantom testing.
- Agreement was analyzed using Bland-Altman analysis, regression, and correlation statistics.
Main Results:
- The GAMCA demonstrated a consistent pressure-length relationship, aligning with beam mechanics.
- Near-perfect rank-order correspondence with COBO was observed (Pearson's r = 0.998-0.999).
- Acceptable repeatability and bias were noted across different humidity levels.
Conclusions:
- A cost-effective corneal aesthesiometer replicating COBO principles can be built for about 1% of the cost.
- The GAMCA shows preserved rank-order fidelity and acceptable repeatability.
- This device is suitable for community screening, ward-based settings, and resource-limited environments, warranting further clinical validation.
